252 related articles for article (PubMed ID: 25821554)
1. Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis.
Virzì GM; Clementi A; de Cal M; Brocca A; Day S; Pastori S; Bolin C; Vescovo G; Ronco C
Oxid Med Cell Longev; 2015; 2015():391790. PubMed ID: 25821554
[TBL] [Abstract][Full Text] [Related]
2. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1.
Virzì GM; Breglia A; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C
Cardiorenal Med; 2018; 8(4):321-331. PubMed ID: 30205401
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.
Virzì GM; Breglia A; Castellani C; Ankawi G; Bolin C; de Cal M; Cianci V; Angelini A; Vescovo G; Ronco C
J Nephrol; 2019 Oct; 32(5):803-810. PubMed ID: 31006081
[TBL] [Abstract][Full Text] [Related]
4. [Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms].
Virzi' GM; de Cal M; Cruz DN; Bolin C; Vescovo G; Ronco C
G Ital Nefrol; 2012; 29(6):690-8. PubMed ID: 23229667
[TBL] [Abstract][Full Text] [Related]
5. Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1.
Virzì GM; Breglia A; Ankawi G; Bolin C; de Cal M; Cianci V; Vescovo G; Ronco C
Cardiorenal Med; 2019; 9(5):308-315. PubMed ID: 31238313
[TBL] [Abstract][Full Text] [Related]
6. Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1.
Breglia A; Virzì GM; Pastori S; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C
Cardiorenal Med; 2018; 8(3):208-216. PubMed ID: 29847820
[TBL] [Abstract][Full Text] [Related]
7. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
8. The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1.
Virzì GM; Clementi A; Milan Manani S; Castellani C; Battaglia GG; Angelini A; Vescovo G; Ronco C
Cardiorenal Med; 2021; 11(5-6):218-225. PubMed ID: 34518452
[TBL] [Abstract][Full Text] [Related]
9. Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation.
Virzì GM; Clementi A; Brocca A; de Cal M; Marcante S; Ronco C
Kidney Blood Press Res; 2016; 41(6):1008-1015. PubMed ID: 28006779
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.
Rajapakse NW; Nanayakkara S; Kaye DM
Pharmacol Ther; 2015 Oct; 154():1-12. PubMed ID: 25989232
[TBL] [Abstract][Full Text] [Related]
11. Advances in the pathogenesis of cardiorenal syndrome type 3.
Clementi A; Virzì GM; Brocca A; de Cal M; Pastori S; Clementi M; Granata A; Vescovo G; Ronco C
Oxid Med Cell Longev; 2015; 2015():148082. PubMed ID: 25821551
[TBL] [Abstract][Full Text] [Related]
12. Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors.
Pastori S; Virzì GM; Brocca A; de Cal M; Clementi A; Vescovo G; Ronco C
Cardiorenal Med; 2015 Apr; 5(2):105-15. PubMed ID: 25999959
[TBL] [Abstract][Full Text] [Related]
13. Changes of thioredoxin, oxidative stress markers, inflammation and muscle/renal damage following intensive endurance exercise.
Sugama K; Suzuki K; Yoshitani K; Shiraishi K; Miura S; Yoshioka H; Mori Y; Kometani T
Exerc Immunol Rev; 2015; 21():130-42. PubMed ID: 25826051
[TBL] [Abstract][Full Text] [Related]
14. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
Giam B; Kaye DM; Rajapakse NW
Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
[TBL] [Abstract][Full Text] [Related]
15. Catalytic iron mediated renal stress responses during experimental cardiorenal syndrome 1 ("CRS-1").
Johnson AC; Zager RA
Transl Res; 2021 Nov; 237():53-62. PubMed ID: 34217897
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis.
Mazzetti I; Grigolo B; Pulsatelli L; Dolzani P; Silvestri T; Roseti L; Meliconi R; Facchini A
Clin Sci (Lond); 2001 Dec; 101(6):593-9. PubMed ID: 11724645
[TBL] [Abstract][Full Text] [Related]
17. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage.
Sahu BD; Kuncha M; Sindhura GJ; Sistla R
Phytomedicine; 2013 Mar; 20(5):453-60. PubMed ID: 23353054
[TBL] [Abstract][Full Text] [Related]
18. The effects of ultrafiltration and diuretic therapies on oxidative stress markers in patients with cardio-renal syndrome.
Sav T; Cecen F; Albayrak ES
Minerva Urol Nefrol; 2017 Aug; 69(4):400-407. PubMed ID: 27097156
[TBL] [Abstract][Full Text] [Related]
19. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
[TBL] [Abstract][Full Text] [Related]
20. Copper/zinc and copper/selenium ratios, and oxidative stress as biochemical markers in recurrent aphthous stomatitis.
Ozturk P; Belge Kurutas E; Ataseven A
J Trace Elem Med Biol; 2013 Oct; 27(4):312-6. PubMed ID: 23664921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
